WEST PHARMACEUTICAL SERVICES (WST) Stock Price, Forecast & Analysis
USA - NYSE:WST - US9553061055 - Common Stock
WST Key Statistics, Chart & Performance
The current stock price of WST is 259.125 USD. In the past month the price decreased by -6.45%. In the past year, price decreased by -18.15%.
WST Latest News, Press Relases and Analysis
WST Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.46 | 215.31B | ||
| DHR | DANAHER CORP | 28.8 | 158.97B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 169.21 | 51.34B | ||
| A | AGILENT TECHNOLOGIES INC | 26.5 | 40.94B | ||
| IQV | IQVIA HOLDINGS INC | 18.61 | 36.79B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 33.48 | 28.85B | ||
| WAT | WATERS CORP | 29.6 | 22.37B | ||
| ILMN | ILLUMINA INC | 27.9 | 18.70B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.25 | 16.57B | ||
| TEM | TEMPUS AI INC | N/A | 11.87B | ||
| RVTY | REVVITY INC | 19.22 | 10.69B | ||
| TECH | BIO-TECHNE CORP | 29.68 | 8.92B |
Related stock screener links
About WST
Company Profile
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,600 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Company Info
WEST PHARMACEUTICAL SERVICES
530 Herman O. West Drive
Exton PENNSYLVANIA 19341 US
CEO: Eric M. Green
Employees: 10600
Phone: 16105942900
WEST PHARMACEUTICAL SERVICES / WST FAQ
What does WST do?
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,600 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Can you provide the latest stock price for WEST PHARMACEUTICAL SERVICES?
The current stock price of WST is 259.125 USD. The price decreased by -0.39% in the last trading session.
Does WST stock pay dividends?
WEST PHARMACEUTICAL SERVICES (WST) has a dividend yield of 0.31%. The yearly dividend amount is currently 0.81.
What is the ChartMill technical and fundamental rating of WST stock?
WST has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What do analysts say about WEST PHARMACEUTICAL SERVICES (WST) stock?
21 analysts have analysed WST and the average price target is 352.25 USD. This implies a price increase of 35.94% is expected in the next year compared to the current price of 259.125.
How is the valuation of WEST PHARMACEUTICAL SERVICES (WST) based on its PE ratio?
The PE ratio for WEST PHARMACEUTICAL SERVICES (WST) is 36.65. This is based on the reported non-GAAP earnings per share of 7.07 and the current share price of 259.125 USD.
What is WEST PHARMACEUTICAL SERVICES worth?
WEST PHARMACEUTICAL SERVICES (WST) has a market capitalization of 18.63B USD. This makes WST a Large Cap stock.
WST Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to WST. When comparing the yearly performance of all stocks, WST is a bad performer in the overall market: 67.26% of all stocks are doing better.
WST Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to WST. Both the health and profitability get an excellent rating, making WST a very profitable company, without any liquidiy or solvency issues.
WST Financial Highlights
Over the last trailing twelve months WST reported a non-GAAP Earnings per Share(EPS) of 7.07. The EPS increased by 4.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.29% | ||
| ROA | 11.98% | ||
| ROE | 16.11% | ||
| Debt/Equity | 0.07 |
WST Forecast & Estimates
21 analysts have analysed WST and the average price target is 352.25 USD. This implies a price increase of 35.94% is expected in the next year compared to the current price of 259.125.
For the next year, analysts expect an EPS growth of 6.12% and a revenue growth 6.25% for WST